This is the new MLex platform. Existing customers should continue to access MLex here until migrated to the new platform. For any migration queries, please contact Customer Services or your Account Manager.

M&A - Roche - Poseida Therapeutics

Roche, a Switzerland-based biotechnology company, has agreed to acquire United States-based partner Poseida Therapeutics, Inc. in a deal with a total cash value of up to $1.5 billion.



To add details to this portfolio regarding legal or economic representatives, please contact editors@mlex.com

Timeline

Parties

Get the inside track, with MLex

With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.


  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

TRY MLEX FREE FOR 14 DAYS